Company: LRHC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032211
Chunk: 2179

Company: La Rosa Holdings Corp.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 7
Chunk 2179
---
February 2024 and July 2024 were fully exercised by the Holder, and (2) the Second Warrant (as defined in the Agreement) issued by the
Company to the Holder in February 2024 was cancelled and extinguished in its entirety due to the full repayment of the Note (as defined
in such warrant).

Securities Purchase Agreement

On February 4, 2025 (the “Closing Date”), the Company and
an institutional investor (the “Investor”) entered into a Securities Purchase Agreement (the “SPA”), pursuant
to which the Company issued to the Investor: (i) a Senior Secured Convertible Note in the original principal amount of $5,500,000 which
matures on February 4, 2027 (the “Initial Note”); and (ii) sixteen (16) warrants (“Incremental Warrants”), each
to purchase additional Notes in an original principal amount up to $2,500,000 at an exercise price of $2,256,250, in substantially the
same form as the Initial Note (“Incremental Notes” and together with the Initial Note, the “Notes”). The purchase
price paid by the Investor under the SPA for the Initial Note and Incremental Warrants was $4,963,750.

The $4,963,750 in gross proceeds from the offering was used by the
Company to pay-off certain indebtedness of the Company, pay certain outstanding fees and expenses (including expenses of the offering,
and fees payable to the placement agent and advisors), acquisitions and general corporate purposes. Of the proceeds from the offering,
$354,450 was paid to satisfy, in full, the remaining balance of the standard merchant cash advance agreements with Cedar Advance, LLC,
$340,421 was paid to satisfy, in full, the remaining balance of the standard merchant cash advance agreement with Arin Funding, LLC and
$910,250 was paid to satisfy, in full, the remaining balance of the senior secured promissory notes with an accredited investor.

Interest on the Note commenced accruing on the issuance date
thereof at an annual rate of 12% per annum computed on the basis of a 360-day year and the actual number of days elapsed in each month
and is payable in arrears for on the first trading day of each fiscal quarter with the first such date being April 1, 2025. Interest may
be paid in certain limited conditions in shares of the Company’s Common Stock and shall otherwise be payable